Vericel (VCEL) Competitors $59.07 +2.72 (+4.83%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends VCEL vs. CTLT, SRPT, QGEN, PCVX, ASND, ROIV, RVMD, LNTH, BPMC, and BBIOShould you be buying Vericel stock or one of its competitors? The main competitors of Vericel include Catalent (CTLT), Sarepta Therapeutics (SRPT), Qiagen (QGEN), Vaxcyte (PCVX), Ascendis Pharma A/S (ASND), Roivant Sciences (ROIV), Revolution Medicines (RVMD), Lantheus (LNTH), Blueprint Medicines (BPMC), and BridgeBio Pharma (BBIO). These companies are all part of the "pharmaceutical products" industry. Vericel vs. Catalent Sarepta Therapeutics Qiagen Vaxcyte Ascendis Pharma A/S Roivant Sciences Revolution Medicines Lantheus Blueprint Medicines BridgeBio Pharma Catalent (NYSE:CTLT) and Vericel (NASDAQ:VCEL) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, community ranking, valuation, analyst recommendations, institutional ownership, earnings and risk. Does the MarketBeat Community believe in CTLT or VCEL? Catalent received 289 more outperform votes than Vericel when rated by MarketBeat users. However, 61.80% of users gave Vericel an outperform vote while only 57.50% of users gave Catalent an outperform vote. CompanyUnderperformOutperformCatalentOutperform Votes64057.50% Underperform Votes47342.50% VericelOutperform Votes35161.80% Underperform Votes21738.20% Do analysts recommend CTLT or VCEL? Catalent presently has a consensus target price of $63.40, suggesting a potential downside of 0.13%. Vericel has a consensus target price of $62.14, suggesting a potential upside of 5.20%. Given Vericel's stronger consensus rating and higher possible upside, analysts plainly believe Vericel is more favorable than Catalent.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Catalent 0 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Vericel 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings and valuation, CTLT or VCEL? Vericel has lower revenue, but higher earnings than Catalent. Catalent is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCatalent$4.38B2.63-$1.04B-$2.26-28.09Vericel$197.52M14.76-$3.18M$0.06984.66 Which has more volatility & risk, CTLT or VCEL? Catalent has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500. Comparatively, Vericel has a beta of 1.72, meaning that its stock price is 72% more volatile than the S&P 500. Does the media favor CTLT or VCEL? In the previous week, Vericel had 28 more articles in the media than Catalent. MarketBeat recorded 29 mentions for Vericel and 1 mentions for Catalent. Catalent's average media sentiment score of 0.28 beat Vericel's score of 0.01 indicating that Catalent is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Catalent 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Vericel 4 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Is CTLT or VCEL more profitable? Vericel has a net margin of 1.56% compared to Catalent's net margin of -9.28%. Vericel's return on equity of 1.48% beat Catalent's return on equity.Company Net Margins Return on Equity Return on Assets Catalent-9.28% -0.66% -0.24% Vericel 1.56%1.48%0.96% SummaryVericel beats Catalent on 13 of the 16 factors compared between the two stocks. Get Vericel News Delivered to You Automatically Sign up to receive the latest news and ratings for VCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCEL vs. The Competition Export to ExcelMetricVericelBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.92B$2.96B$5.20B$9.14BDividend YieldN/A1.91%5.13%4.02%P/E Ratio984.6644.1187.2517.09Price / Sales14.76275.871,263.9177.22Price / Cash3,376.46192.9043.7736.04Price / Book12.493.965.314.79Net Income-$3.18M-$41.02M$122.54M$224.99M7 Day Performance0.68%1.13%1.44%2.37%1 Month Performance4.55%-1.72%2.51%4.40%1 Year Performance48.90%-2.23%25.32%20.10% Vericel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCELVericel1.9238 of 5 stars$59.07+4.8%$62.14+5.2%+48.9%$2.92B$197.52M984.66300CTLTCatalent1.2979 of 5 stars$63.48flat$63.40-0.1%N/A$11.52B$4.42B-28.0916,900Analyst ForecastSRPTSarepta Therapeutics4.9597 of 5 stars$118.06-5.4%$178.71+51.4%+2.0%$11.28B$1.64B94.451,314QGENQiagen4.1996 of 5 stars$45.98+2.9%$51.50+12.0%-1.1%$10.49B$1.97B117.905,967PCVXVaxcyte2.2218 of 5 stars$80.93-0.2%$145.71+80.0%+40.8%$10.09BN/A-17.59160ASNDAscendis Pharma A/S3.6284 of 5 stars$133.43+3.3%$192.07+43.9%-2.9%$8.10B$327.43M-16.51640Short Interest ↓Analyst RevisionROIVRoivant Sciences3.653 of 5 stars$10.70+0.7%$17.93+67.6%+7.7%$7.79B$129.13M1.89860RVMDRevolution Medicines4.5331 of 5 stars$42.38+1.4%$66.25+56.3%+49.6%$7.13B$742,000.00-11.80250LNTHLantheus4.5427 of 5 stars$95.12-0.8%$131.86+38.6%+72.3%$6.61B$1.50B15.83700BPMCBlueprint Medicines1.8809 of 5 stars$103.16+18.0%$122.72+19.0%+35.8%$6.55B$434.42M-48.89640Short Interest ↑BBIOBridgeBio Pharma4.0926 of 5 stars$33.56+15.4%$48.08+43.3%-7.8%$6.34B$217.77M-13.93400Short Interest ↑High Trading Volume Related Companies and Tools Related Companies CTLT Competitors SRPT Competitors QGEN Competitors PCVX Competitors ASND Competitors ROIV Competitors RVMD Competitors LNTH Competitors BPMC Competitors BBIO Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:VCEL) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vericel Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vericel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCEL Stock Alerts